JP2012521745A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521745A5
JP2012521745A5 JP2012501093A JP2012501093A JP2012521745A5 JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5 JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5
Authority
JP
Japan
Prior art keywords
cancer
mitochondrial fusion
mammal
acid sequence
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012501093A
Other languages
English (en)
Japanese (ja)
Other versions
JP5734947B2 (ja
JP2012521745A (ja
Filing date
Publication date
Priority claimed from PCT/CA2009/000351 external-priority patent/WO2009117811A1/en
Application filed filed Critical
Priority claimed from PCT/CA2010/000423 external-priority patent/WO2010115261A1/en
Publication of JP2012521745A publication Critical patent/JP2012521745A/ja
Publication of JP2012521745A5 publication Critical patent/JP2012521745A5/ja
Application granted granted Critical
Publication of JP5734947B2 publication Critical patent/JP5734947B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012501093A 2009-03-27 2010-03-29 異常型ミトコンドリアｄｎａ、関連融合転写物および翻訳産物、並びにそのハイブリダイゼーションプローブ Expired - Fee Related JP5734947B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CA2009/000351 WO2009117811A1 (en) 2008-03-28 2009-03-27 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
CAPCT/CA2009/000351 2009-03-27
PCT/CA2010/000423 WO2010115261A1 (en) 2009-03-27 2010-03-29 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor

Publications (3)

Publication Number Publication Date
JP2012521745A JP2012521745A (ja) 2012-09-20
JP2012521745A5 true JP2012521745A5 (enExample) 2013-05-16
JP5734947B2 JP5734947B2 (ja) 2015-06-17

Family

ID=42937093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012501093A Expired - Fee Related JP5734947B2 (ja) 2009-03-27 2010-03-29 異常型ミトコンドリアｄｎａ、関連融合転写物および翻訳産物、並びにそのハイブリダイゼーションプローブ

Country Status (6)

Country Link
EP (2) EP2411522B1 (enExample)
JP (1) JP5734947B2 (enExample)
KR (1) KR101720555B1 (enExample)
AU (1) AU2010234238B2 (enExample)
RU (1) RU2011137486A (enExample)
WO (1) WO2010115261A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2274426B1 (en) 2008-03-28 2016-11-16 MDNA Life Sciences Inc. Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
TWI709188B (zh) 2018-09-27 2020-11-01 財團法人工業技術研究院 基於機率融合的分類器、分類方法及分類系統
CN113025633B (zh) * 2019-12-09 2024-08-27 武汉纽福斯生物科技有限公司 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6218117B1 (en) * 1998-06-15 2001-04-17 Mitokor Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios
US20030162174A1 (en) * 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
EP1397508A2 (en) * 2001-06-11 2004-03-17 1304854 Ontario Ltd Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
NZ562928A (en) * 2005-04-18 2011-01-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
EP2203570B1 (en) * 2007-09-26 2014-04-23 Mitomics Inc. 3.4 kb mitochondrial dna deletion for use in the detection of cancer
EP2274426B1 (en) 2008-03-28 2016-11-16 MDNA Life Sciences Inc. Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor

Similar Documents

Publication Publication Date Title
JP2015533788A5 (enExample)
Yamashita et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis
US10705089B2 (en) Methods and kits for the diagnosis of cancer
JP6715770B2 (ja) モノクローナル抗ｔｋ１抗体
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2014239695A5 (enExample)
BR112018070823A2 (pt) anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno.
JP2009001563A5 (enExample)
JP2011512817A5 (enExample)
NZ603492A (en) Humanized anti-factor d antibodies and uses thereof
JP2017518366A5 (enExample)
WO2014036495A4 (en) Diagnostic assays and kits for detection of folate receptor 1
JP2014061000A5 (enExample)
JP2016536330A5 (enExample)
JP2014508298A5 (enExample)
ATE474857T1 (de) Antikörper gegen ein epitop auf agr2, assays und hybridome
JP6815331B2 (ja) 前立腺がんの分析のための組成物及び方法
JP2009539082A5 (enExample)
WO2008012362A3 (en) New protein isoforms and uses thereof
JP2012501318A5 (enExample)
JP2016536568A5 (enExample)
WO2010045495A3 (en) Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
WO2009121024A3 (en) Methods for detecting antibodies
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
JP2018507254A5 (enExample)